Rentosertib, built with generative AI for scarred lungs, starts a year-long study after protein clocks suggested treated patients looked biologically younger.

Six independent protein-based aging clocks moved younger in forty-two patients with idiopathic pulmonary fibrosis, with the strongest signal at four weeks on a mid-range dose.

A polymer nanogel crossed into the brain, lowered one protein in support cells, and produced working neurons plus better memory in mice.

A custom treatment built from each patient's tumor mutations, given with an existing immunotherapy, met its main goals in a large late-stage study and relies on computational ranking of targets.

University of Chicago scientists rewired Bifidobacterium longum to pump SumIL-2 inside tumors, suppressing pancreatic cancer growth in mouse models.

NUS Medicine, DayOne and Cortical Labs deploy 20 living-neuron CL1 units in a server rack cutting AI compute power to 30W per machine. "This is less power than a handheld-calculator".

UW–Madison researchers identify genes that block CRISPR success, offering a roadmap for safer gene therapy—particularly for inherited eye diseases.

A self-replicating synthetic cell has moved artificial life from theory to reality, opening a new chapter in synthetic biology and origin-of-life research.

New technology from the University of Florida uses stable DNA guides to target RNA with greater precision and lower cost than traditional methods.